Endogenous bradykinin and B1-B5 during angiotensin-converting enzyme inhibitor-associated angioedema.
Publication
, Journal Article
Hubers, SA; Kohm, K; Wei, S; Yu, C; Nian, H; Grabert, R; Sexton, DJ; Brown, NJ
Published in: J Allergy Clin Immunol
November 2018
Bradykinin concentrations and the ratio of bradykinin to its stable metabolite BK1–5 (RPPGF) were significantly increased in patients presenting with angiotensin-converting enzyme (ACE) inhibitor-associated angioedema compared to ACE inhibitor-treated controls. Cleavage of high molecular weight kininogen was not increased in patients with ACE inhibitor-associated angioedema, indicating that increased bradykinin concentrations result from decreased degradation.
Duke Scholars
Published In
J Allergy Clin Immunol
DOI
EISSN
1097-6825
Publication Date
November 2018
Volume
142
Issue
5
Start / End Page
1636 / 1639.e5
Location
United States
Related Subject Headings
- Quinapril
- Peptide Fragments
- Middle Aged
- Male
- Lisinopril
- Kininogen, High-Molecular-Weight
- Humans
- Female
- Enalapril
- Bradykinin
Citation
APA
Chicago
ICMJE
MLA
NLM
Hubers, S. A., Kohm, K., Wei, S., Yu, C., Nian, H., Grabert, R., … Brown, N. J. (2018). Endogenous bradykinin and B1-B5 during angiotensin-converting enzyme inhibitor-associated angioedema. J Allergy Clin Immunol, 142(5), 1636-1639.e5. https://doi.org/10.1016/j.jaci.2018.06.037
Hubers, Scott A., Kevin Kohm, Shouzuo Wei, Chang Yu, Hui Nian, Ryan Grabert, Daniel J. Sexton, and Nancy J. Brown. “Endogenous bradykinin and B1-B5 during angiotensin-converting enzyme inhibitor-associated angioedema.” J Allergy Clin Immunol 142, no. 5 (November 2018): 1636-1639.e5. https://doi.org/10.1016/j.jaci.2018.06.037.
Hubers SA, Kohm K, Wei S, Yu C, Nian H, Grabert R, et al. Endogenous bradykinin and B1-B5 during angiotensin-converting enzyme inhibitor-associated angioedema. J Allergy Clin Immunol. 2018 Nov;142(5):1636-1639.e5.
Hubers, Scott A., et al. “Endogenous bradykinin and B1-B5 during angiotensin-converting enzyme inhibitor-associated angioedema.” J Allergy Clin Immunol, vol. 142, no. 5, Nov. 2018, pp. 1636-1639.e5. Pubmed, doi:10.1016/j.jaci.2018.06.037.
Hubers SA, Kohm K, Wei S, Yu C, Nian H, Grabert R, Sexton DJ, Brown NJ. Endogenous bradykinin and B1-B5 during angiotensin-converting enzyme inhibitor-associated angioedema. J Allergy Clin Immunol. 2018 Nov;142(5):1636-1639.e5.
Published In
J Allergy Clin Immunol
DOI
EISSN
1097-6825
Publication Date
November 2018
Volume
142
Issue
5
Start / End Page
1636 / 1639.e5
Location
United States
Related Subject Headings
- Quinapril
- Peptide Fragments
- Middle Aged
- Male
- Lisinopril
- Kininogen, High-Molecular-Weight
- Humans
- Female
- Enalapril
- Bradykinin